242 related articles for article (PubMed ID: 7053574)
21. Correlation of the inability to sustain growth in defined serum-free medium with the suppression of tumorigenicity in Wilms' nephroblastoma.
Dowdy SF; Weissman BE; Stanbridge EJ
J Cell Physiol; 1991 May; 147(2):248-55. PubMed ID: 1645741
[TBL] [Abstract][Full Text] [Related]
22. Suppressor genes for malignant and anchorage-independent phenotypes located on human chromosome 9 have no dosage effects.
Islam MQ; Islam K
Cytogenet Cell Genet; 2000; 88(1-2):103-9. PubMed ID: 10773681
[TBL] [Abstract][Full Text] [Related]
23. The ability of normal mouse cells to reduce the malignant potential of transformed mouse bladder epithelial cells depends on their somatic origin.
Cowell JK; Franks LM
Int J Cancer; 1984 May; 33(5):657-67. PubMed ID: 6724740
[TBL] [Abstract][Full Text] [Related]
24. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
[TBL] [Abstract][Full Text] [Related]
25. Clonal analysis of the expression of multiple transformation phenotypes and tumorigenicity by morphologically transformed 10T1/2 cells.
Smith GJ; Bell WN; Grisham JW
Cancer Res; 1993 Feb; 53(3):500-8. PubMed ID: 8425183
[TBL] [Abstract][Full Text] [Related]
26. Microfilament bundles in transformed mouse CLID x transformed CHO cell hybrids. Correlation with tumorigenicity in nude mice.
Celis JE; Small JV; Kaltoft K; Celis A
Exp Cell Res; 1979 Apr; 120(1):79-86. PubMed ID: 571343
[No Abstract] [Full Text] [Related]
27. Growth-regulatory control of human cell hybrids in nude mice.
Stanbridge EJ; Ceredig R
Cancer Res; 1981 Feb; 41(2):573-80. PubMed ID: 7448804
[TBL] [Abstract][Full Text] [Related]
28. Lack of tumor suppression but induced loss of copies of indigenous chromosome 10 in vitro following microcell-mediated transfer of a deleted human der(9)t(X;9) chromosome to Syrian hamster BHK-191-5C cells.
Islam MQ; Islam K
Cytogenet Cell Genet; 1999; 87(1-2):11-8. PubMed ID: 10640804
[TBL] [Abstract][Full Text] [Related]
29. Analysis of myogenesis by somatic cell hybridization. II. Retention of myogenic competence and suppression of transformed properties in hybrids between differentiation competent and incompetent rat L6 myoblasts.
Lawrence JB; Coleman JR
J Cell Physiol; 1983 Jan; 114(1):99-110. PubMed ID: 6826666
[TBL] [Abstract][Full Text] [Related]
30. Genetic analysis of an in vitro model system for human papillomavirus type 16-associated tumorigenesis.
Seagon S; Dürst M
Cancer Res; 1994 Nov; 54(21):5593-8. PubMed ID: 7923202
[TBL] [Abstract][Full Text] [Related]
31. A threshold effect in the induction of tumorigenicity of an established human cell line by v-mos.
O'Hara BM; Blair DG
Oncogene; 1988 Sep; 3(3):295-9. PubMed ID: 2974527
[TBL] [Abstract][Full Text] [Related]
32. Loss of the tumorigenic phenotype with in vitro, but not in vivo, passaging of a novel series of human bronchial epithelial cell lines: possible role of an alpha 5/beta 1-integrin-fibronectin interaction.
Schiller JH; Bittner G
Cancer Res; 1995 Dec; 55(24):6215-21. PubMed ID: 8521416
[TBL] [Abstract][Full Text] [Related]
33. Noncoordinate expression of SV40-induced transformation and tumorigenicity in mouse cell hybrids.
Howell N; Sager R
Somatic Cell Genet; 1979 Jan; 5(1):129-43. PubMed ID: 219552
[TBL] [Abstract][Full Text] [Related]
34. Examination of the oncogenic potential of H19 gene in HeLa x normal human fibroblast hybrid cells.
Tsujimoto H; Nishizuka S; Redpath LJ; Stanbridge EJ
Int J Oncol; 2001 Jul; 19(1):89-95. PubMed ID: 11408927
[TBL] [Abstract][Full Text] [Related]
35. Tumorigenicity of human HT1080 fibrosarcoma X normal fibroblast hybrids: chromosome dosage dependency.
Benedict WF; Weissman BE; Mark C; Stanbridge EJ
Cancer Res; 1984 Aug; 44(8):3471-9. PubMed ID: 6744274
[TBL] [Abstract][Full Text] [Related]
36. Expression of the transformed phenotype and tumorigenicity in somatic cell hybrids.
Marshall CJ
J Cell Sci; 1979 Oct; 39():319-27. PubMed ID: 575140
[TBL] [Abstract][Full Text] [Related]
37. Chromosomal radiosensitivity during the G2 cell cycle period and cytopathology of human normal x tumor cell hybrids.
Sanford KK; Parshad R; Stanbridge EJ; Frost JK; Jones GM; Wilkinson JE; Tarone RE
Cancer Res; 1986 Apr; 46(4 Pt 2):2045-9. PubMed ID: 3948180
[TBL] [Abstract][Full Text] [Related]
38. Suppression of tumorigenicity in somatic cell hybrids. IV. Chromosomes of normal human cells associated with suppression of tumorigenicity in hybrids with D98AH2 carcinoma cells.
Klinger HP; Kaelbling M
Cytogenet Cell Genet; 1986; 42(4):225-35. PubMed ID: 3463446
[TBL] [Abstract][Full Text] [Related]
39. Suppression of tumorigenicity, but not invasion, in glioblastoma/HeLa cell hybrids.
Ess K; Chen H; Kier A; Brackenbury R
J Cell Physiol; 1995 Mar; 162(3):341-7. PubMed ID: 7860642
[TBL] [Abstract][Full Text] [Related]
40. [The role of glycosphingolipids in the expression of neoplastic phenotype. III. Changes in glycosphingolipids related to the capacity of neoplastic cells for metastasis and tumor growth in vivo].
Ugorski M
Postepy Hig Med Dosw; 1992; 46(2):191-208. PubMed ID: 1470581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
